Low dose of S(+)-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in viv
For over a decade, many clinics have offered multiday infusions of ketamine in conjunction with opio...
Ketamine is a phencyclidine derivative, which functions primarily as an antagonist of the N-methyl-d...
Ketamine binds non-competitive against a phencyclidine receptors bound N-methyl-D-aspartate (NMDA), ...
Although spinal cord stimulation (SCS) is an established therapy for chronic neuropathic pain, still...
Effects caused by the spinal administration of ketamine S (+) 5 % with no preservatives, using a sin...
Background: Systemic ketamine can trigger apoptosis in the brain of rodents and primates during susc...
Although spinal cord stimulation (SCS) is an established therapy for chronic neuropathic pain, still...
Mu-opioid agonists and N-methyl-D-aspartate (NMDA) receptor antagonists have been shown to attenuate...
Chemistry, MultidisciplinaryPharmacology & PharmacySCI(E)中国科技核心期刊(ISTIC)0MEETING ABSTRACT110-110...
Subhypnotic doses of ketamine cause a transient decrease in sensitivity to somatic pain. Analgesia c...
WOS: 000305422000026PubMed: 22436574Background: The aim of this study was to investigate and to comp...
BACKGROUND: The N-methyl-D-aspartate receptor antagonist ketamine and its active enantiomer, S(+)-ke...
OBJECTIVE: In pain management, alternative medications are necessary due to the development of toler...
Spinal cord injury (SCI) impairs mobility and often results in complications like intractable neurop...
Aims: The aim of the study was to explore the analgesic effect of the N-methyl-D-aspartate receptor ...
For over a decade, many clinics have offered multiday infusions of ketamine in conjunction with opio...
Ketamine is a phencyclidine derivative, which functions primarily as an antagonist of the N-methyl-d...
Ketamine binds non-competitive against a phencyclidine receptors bound N-methyl-D-aspartate (NMDA), ...
Although spinal cord stimulation (SCS) is an established therapy for chronic neuropathic pain, still...
Effects caused by the spinal administration of ketamine S (+) 5 % with no preservatives, using a sin...
Background: Systemic ketamine can trigger apoptosis in the brain of rodents and primates during susc...
Although spinal cord stimulation (SCS) is an established therapy for chronic neuropathic pain, still...
Mu-opioid agonists and N-methyl-D-aspartate (NMDA) receptor antagonists have been shown to attenuate...
Chemistry, MultidisciplinaryPharmacology & PharmacySCI(E)中国科技核心期刊(ISTIC)0MEETING ABSTRACT110-110...
Subhypnotic doses of ketamine cause a transient decrease in sensitivity to somatic pain. Analgesia c...
WOS: 000305422000026PubMed: 22436574Background: The aim of this study was to investigate and to comp...
BACKGROUND: The N-methyl-D-aspartate receptor antagonist ketamine and its active enantiomer, S(+)-ke...
OBJECTIVE: In pain management, alternative medications are necessary due to the development of toler...
Spinal cord injury (SCI) impairs mobility and often results in complications like intractable neurop...
Aims: The aim of the study was to explore the analgesic effect of the N-methyl-D-aspartate receptor ...
For over a decade, many clinics have offered multiday infusions of ketamine in conjunction with opio...
Ketamine is a phencyclidine derivative, which functions primarily as an antagonist of the N-methyl-d...
Ketamine binds non-competitive against a phencyclidine receptors bound N-methyl-D-aspartate (NMDA), ...